I agree with you, Anavex does not get any respect from the general market. Yesterday's share price action was very disappointing. The news was deemed excellent and we only gained 8%. Unless further good news keeps coming out, the share price will continue to slightly dwindle, which has basically been the case since the stock was trading in the 6's.
The street doesn't know and/or care about Anavex, I think that will change when we release good results from the Rett Trial meaning eventual FDA approval or data from the Alz trial before that.